CV Sciences Inc (CVSI): 💥🇺🇸 “THERE’S ALS...

Next 10 Prev Next

Send PM Follow Ignore

Followers	4
Posts	3186
Boards Moderated	0
Alias Born	08/23/2022

Thomas@yahoo

Re: Thomas@yahoo post# 84017

Wednesday, 06/11/2025 9:19:01 AM

Wednesday, June 11, 2025 9:19:01 AM

💥🇺🇸 “THERE’S ALSO A FEELING OF TRUST IN PRESIDENT DONALD TRUMP, WHO SIGNED THE INITIAL FARM BILL INTO LAW”.🇺🇸💥

💥🇺🇸 “THE PRESIDENT WHO PASSED THE 2018 FARM BILL IS THE SAME PRESIDENT IN THE WHITE HOUSE TODAY, WHICH IS WHY WE
REMAIN CONFIDENT THAT CONGRESS WILL CONTINUE TO SUPPORT THE HEMP INDUSTRY “.💥🇺🇸

https://mjbizdaily.com/will-hemp-derived-thc-issue-make-congress-take-action/

https://intpolicydigest.org/hemp-is-good-for-america-s-economy-and-its-future/

Bullish

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent CVSI News

Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 08:10:09 PM
CV Sciences, Inc. Reports First Quarter-End 2026 Financial Results • ACCESS Newswire • 05/14/2026 08:00:00 PM
CV Sciences, Inc. To Announce First Quarter 2026 Results On May 14, 2026 • ACCESS Newswire • 05/12/2026 10:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:04:10 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 09:14:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:06:03 PM
CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results • ACCESS Newswire • 03/26/2026 08:00:00 PM
CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026 • ACCESS Newswire • 03/24/2026 09:00:00 PM
CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth • ACCESS Newswire • 03/10/2026 09:00:00 PM
CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness • ACCESS Newswire • 02/26/2026 01:30:00 PM
CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD • ACCESS Newswire • 12/23/2025 12:00:00 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:19:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:04:08 PM
CV Sciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 09:00:00 PM
CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 • ACCESS Newswire • 11/10/2025 11:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:05:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:24:23 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:23:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:01:09 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent CVSI News

More CVSI News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent CVSI News

Go Ad-Free